Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Merck Lipha

Division of Merck KGaA

Latest From Merck Lipha

Alinea Pharmaceuticals Inc.

Alinea Pharmaceuticals was founded recently around three in-licensed development programs, encompassing a Phase II-ready molecule to treat diabetic complications, a set of leads against a novel serum glucose-regulating target of significant interest to Big Pharma, and a research program around novel methods for lipid control.
BioPharmaceutical Research and Development Strategies
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Lipha Chemicals
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • France
  • Parent & Subsidiaries
  • Merck KGaA
  • Senior Management
  • Contact Info
  • Merck Lipha
    Phone: (33) 4 72 78 25 25
    37, rue Saint Romain
    Lyon, 69379